Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field
AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field
AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field
Submitted by
admin
on May 20, 2013 - 11:20am
Source:
Seeking Alpha
News Tags:
AbbVie
celiac disease
BioLineRx
Alvine
AVL003
Headline:
AbbVie's Latest Drug Deal Marks A Shift In The Celiac Disease Therapeutics Field
Do Not Allow Advertisers to Use My Personal information
